Results
ANG Lifesciences Approves Q2 FY26 Results, Appoints Director
ANG Lifesciences board approved unaudited standalone and consolidated financial results for Q2 and H1 ended September 30, 2026.
Appointed Mrs. Preeti Sarin as Additional Independent Director for five-
